Literature DB >> 19106616

The p53 mRNA-Mdm2 interaction.

Nadia Naski1, Madhavsai Gajjar, Karima Bourougaa, Laurence Malbert-Colas, Robin Fåhraeus, Marco M Candeias.   

Abstract

The E3 ligase Mdm2 is a key regulator of p53 activity via a complex regulatory feedback system that involves all levels of expression control including transcription, mRNA translation and protein degradation. Best known is the effect of p53 on Mdm2 transcription and the capacity of Mdm2 to target p53 for degradation, but more recently the role of Mdm2 as a positive regulator of p53 activity has also started to emerge. Mdm2 stimulates p53 mRNA translation by binding the p53 mRNA and, interestingly, this interaction also suppresses Mdm2's capacity to promote p53 polyubiquitination and degradation. Another interesting aspect of the p53 mRNA-Mdm2 interaction is that the p53 mRNA sequence encoding the amino acids which bind the N-terminus of Mdm2 is the same that interacts with the Mdm2 RING domain. Indeed, the regulatory elements for controlling Mdm2-dependent expression of p53 are derived from the same p53 genomic sequence. In addition, the RNA binding and the E3 ligase domain of Mdm2 overlap, indicati that the two functions of Mdm2 to control p53 synthesis and degradation have co-evolved in parallel in both p53 and Mdm2. Here we illustrate how the p53-Mdm2 protein-protein and p53 mRNA-Mdm2 interactions affect Mdm2-mediated control of p53 expression using the Phe19Ala p53 mutant. We discuss how the new insights into the regulation of p53 expression levels can help to shed light on the origin of this elegant feedback system and on the function of Mdm2 isoforms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19106616     DOI: 10.4161/cc.8.1.7326

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  28 in total

1.  A single synonymous mutation determines the phosphorylation and stability of the nascent protein.

Authors:  Konstantinos Karakostis; Sivakumar Vadivel Gnanasundram; Ignacio López; Aikaterini Thermou; Lixiao Wang; Karin Nylander; Vanesa Olivares-Illana; Robin Fåhraeus
Journal:  J Mol Cell Biol       Date:  2019-03-01       Impact factor: 6.216

2.  Mdm2 and MdmX as Regulators of Gene Expression.

Authors:  Lynn Biderman; James L Manley; Carol Prives
Journal:  Genes Cancer       Date:  2012-03

3.  Efficient mRNA polyadenylation requires a ubiquitin-like domain, a zinc knuckle, and a RING finger domain, all contained in the Mpe1 protein.

Authors:  Susan D Lee; Claire L Moore
Journal:  Mol Cell Biol       Date:  2014-08-18       Impact factor: 4.272

Review 4.  Mdm2 links genotoxic stress and metabolism to p53.

Authors:  Zhongfeng Wang; Baojie Li
Journal:  Protein Cell       Date:  2011-01-08       Impact factor: 14.870

5.  Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia.

Authors:  Jianting Long; Brian Parkin; Peter Ouillette; Dale Bixby; Kerby Shedden; Harry Erba; Shaomeng Wang; Sami N Malek
Journal:  Blood       Date:  2010-04-19       Impact factor: 22.113

6.  Silencing of ribosomal protein S9 elicits a multitude of cellular responses inhibiting the growth of cancer cells subsequent to p53 activation.

Authors:  Mikael S Lindström; Monica Nistér
Journal:  PLoS One       Date:  2010-03-08       Impact factor: 3.240

7.  Designing focused chemical libraries enriched in protein-protein interaction inhibitors using machine-learning methods.

Authors:  Christelle Reynès; Hélène Host; Anne-Claude Camproux; Guillaume Laconde; Florence Leroux; Anne Mazars; Benoit Deprez; Robin Fahraeus; Bruno O Villoutreix; Olivier Sperandio
Journal:  PLoS Comput Biol       Date:  2010-03-05       Impact factor: 4.475

8.  Splicing up mdm2 for cancer proteome diversity.

Authors:  Danielle R Okoro; Melissa Rosso; Jill Bargonetti
Journal:  Genes Cancer       Date:  2012-03

Review 9.  Regulatory RNAs and control of epigenetic mechanisms: expectations for cognition and cognitive dysfunction.

Authors:  Anderson A Butler; William M Webb; Farah D Lubin
Journal:  Epigenomics       Date:  2015-09-14       Impact factor: 4.778

Review 10.  p53-independent effects of Mdm2.

Authors:  Stephen Bohlman; James J Manfredi
Journal:  Subcell Biochem       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.